Company attributes
Location
B2X
CEO
Founder
AngelList URL
Pitchbook URL
Legal Name
Intezyne Technologies, Inc.
Legal classification
Date Incorporated
June 15, 2004
Number of Employees (Ranges)
1 – 10
Email Address
info@bold-therapeutics.com0
investor.relations@intezyne.com0
carly.hastings@intezyne.com0
Phone Number
+181391021200
Full Address
3802 Spectrum Blvd., Suite 202 Tampa, FL 336120
3720 Spectrum Boulevard Suite 202 Tampa, FL 33612 United States
CIK Number
Investors
DUNS Number
2002948
Total Funding Amount (USD)
19,851,359
Latest Funding Round Date
October 2017
Latest Funding Type
Patents Assigned (Count)
33
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Intezyne is a clinical-stage biotechnology company focused on increasing the effectiveness of cancer treatments through the application of a diverse portfolio of proprietary assets.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
